Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data.

CNS Drugs · 2024 · PMC11098931 · PMID 38635089

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Overall, the listed limitations are unlikely to be of substantial importance for the observations of highly significant increases in metabolizer phenotypes among patients expressing LCD versus NCD before clozapine treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.